Resmed Agrees to Sell its Software Business to a Private Equity Firm

Resmed announced today it is selling its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on healthcare.

The deal is part of Resmed’s 2030 strategy to focus on high-growth, scalable opportunities in sleep health, breathing health, and connected home-based healthcare. The divestiture also strengthens the company’s ability to reallocate capital and resources toward innovation, operational scale, and long-term value creation across its connected, home-based care ecosystem.

“Today’s announcement is about our disciplined approach to portfolio management and our commitment to driving long-term growth,” Resmed Chairman/CEO Mick Farrell said. “By focusing on areas where we see the greatest opportunity for sleep health innovation and impact, we are strengthening our ability to deliver life-changing health technologies, improve patient outcomes, and create value for our stakeholders. We are confident MatrixCare and its affiliated businesses will continue to support team members and drive growth under new ownership with a dedicated focus on the long-term care market.”

MatrixCare provides software solutions to more than 15,000 providers and supports skilled nursing, senior living and long-term care, life planning communities and home health and hospice care.

The transaction includes MatrixCare and related software offerings historically sold under the MatrixCare brand, including Healthcare First, Citus, and home health and hospice solutions (collectively defined as the MatrixCare business). It excludes Resmed’s other software businesses—Brightree in the United States and MEDIFOX DAN in Germany.

“Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living and home health and hospice providers,” Frazier Healthcare Partners General Partner Ryan Lucero stated. “We are thrilled to partner with the MatrixCare team and plan to invest aggressively in product innovation to help providers deliver better outcomes as the post-acute care landscape continues to evolve.” 

The transaction is expected to close during the first quarter of Resmed’s fiscal year 2027, subject to required regulatory approvals and customary closing conditions. Until closing, MatrixCare will continue to operate as part of Resmed, with no changes to customer service or support.

Resmed will provide further updates regarding the financial impact of the transaction in its regulatory filings for the fourth quarter of its fiscal year 2026, consistent with regulatory requirements.

Resmed is pioneering technology to empower millions of people in 140 countries to live happier, healthier lives. Its artificial intelligence-powered digital health solutions, cloud-connected devices, and intelligent software make home healthcare more personalized, accessible, and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home.

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 35 years. Frazier partners with strong management teams while leveraging its internal operating resources and network to build companies. Frazier is headquartered in Seattle, and maintains an office in New York City. The company invests broadly across the United States, Canada, and Europe.